Sponsor Pipeline

Pierre Fabre Medicament Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
10
Active Trials
4
Recruiting
2
Phase 3
5
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
2
Phase 1/2
3
Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03394365 A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated… Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) Recruiting
NCT05270044 Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation. Melanoma Active, Not Recruiting
Phase 2
NCT05195632 Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E… Non-Small Cell Lung Cancer Active, Not Recruiting
NCT04554914 A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV)… Epstein-Barr Virus (EBV)-Associated Diseases Active, Not Recruiting
Phase 1/2
NCT06669117 FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With… Solid Tumor Recruiting
NCT06043817 First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or… Non-Small Cell Lung Cancer Recruiting
NCT06567015 Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs Non-small Cell Lung Cancer (NSCLC) Recruiting
Phase 1
NCT04913285 A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive… Solid Tumor, Adult Active, Not Recruiting
Not specified
NCT07096206 Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in… X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Active, Not Recruiting
NCT06500494 To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer… Advanced Breast Cancer Active, Not Recruiting
Disease Areas
Get alerts when Pierre Fabre Medicament's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free